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Abstract
Background: Transmission of tuberculosis (TB) in prisons has been reported worldwide to be much higher than that
reported for the corresponding general population.
Methods and Findings: A systematic review has been performed to assess the risk of incident latent tuberculosis infection
(LTBI) and TB disease in prisons, as compared to the incidence in the corresponding local general population, and to
estimate the fraction of TB in the general population attributable (PAF%) to transmission within prisons. Primary peer-
reviewed studies have been searched to assess the incidence of LTBI and/or TB within prisons published until June 2010;
both inmates and prison staff were considered. Studies, which were independently screened by two reviewers, were eligible
for inclusion if they reported the incidence of LTBI and TB disease in prisons. Available data were collected from 23 studies
out of 582 potentially relevant unique citations. Five studies from the US and one from Brazil were available to assess the
incidence of LTBI in prisons, while 19 studies were available to assess the incidence of TB. The median estimated annual
incidence rate ratio (IRR) for LTBI and TB were 26.4 (interquartile range [IQR]: 13.0–61.8) and 23.0 (IQR: 11.7–36.1),
respectively. The median estimated fraction (PAF%) of tuberculosis in the general population attributable to the exposure in
prisons for TB was 8.5% (IQR: 1.9%–17.9%) and 6.3% (IQR: 2.7%–17.2%) in high- and middle/low-income countries,
respectively.
Conclusions: The very high IRR and the substantial population attributable fraction show that much better TB control in
prisons could potentially protect prisoners and staff from within-prison spread of TB and would significantly reduce the
national burden of TB. Future studies should measure the impact of the conditions in prisons on TB transmission and assess
the population attributable risk of prison-to-community spread.
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Occurrence of active tuberculosis (TB) in prisons is usually
reported to be much higher than the average levels reported for
the corresponding general population [1,2]. In prisons located in
developing countries TB has been reported as the most common
cause of death [3]. High levels of TB in prison populations are
likely to be attributable to the fact that a disproportionate number
of prisoners are from population groups already at high risk of TB
infection and TB disease (for example, alcohol or drug users,
homeless people, mentally ill individuals, former prisoners, and
illegal immigrants from areas characterized by high TB preva-
lence). Furthermore, the prison setting, where segregation criteria
are based on crime characteristics rather than on public health
concerns, may facilitate transmission. In addition, overcrowding,
late case detection, inadequate treatment of infectious cases, high
turnover of prisoners, and poor implementation of TB infection
control measures are all known factors contributing to transmis-
sion of Mycobacterium tuberculosis. Finally, prisoners may be at risk of
rapid progression of latent TB infection (LTBI) to TB disease
following recent infection or reactivation of latent infection
through coexisting pathology, particularly HIV infection, intrave-
nous drug use, and poor nutritional status [3,4].
Moreover, prisons represent a reservoir for disease transmission
to the community at large; the TB infection may spread into the
general population through prison staff, visitors, and close contacts
of released prisoners [5]. The transmission dynamics between
prisoners and the general population has been hypothesized to
play a key role in driving overall population-level TB incidence,
prevalence, and mortality rates [4].
Overlooking TB prevention and control in prisons settings can
carry serious consequences for both prisoners and the general
community, in particular in those countries where poor TB
control, lack of TB infection control measures, and incarceration
rates are high [3].
The main objectives of the present study were to assess, by
reviewing the published literature, the consequences of within-
prison spread of TB, estimating the relative risk and risk difference
for incident latent TB infection (LTBI) and TB disease in prisons
worldwide, as compared to the incidence in the corresponding
local general population and the fraction (percent) of LTBI and
TB in the general population attributable (PAF%) to the exposure
in prisons. The aim of this study is to provide relative and absolute
estimates of the risk of TB associated with incarceration, and of the
potential impact of specific preventive measures to control TB
transmission in the prison setting.
Methods
Search Strategy
An initial search of the available literature for systematic reviews
or meta-analyses reporting estimates of the occurrence of LTBI
and TB incidence in prisons did not identify potentially relevant
studies. Details on the search strategy adopted to identify original
primary studies in English, French, Italian, Spanish, Portuguese,
or Russian, published since January 1980 through June 2010, and
reporting data on the incidence of LTBI and TB in prisons, are
reported in Text S2.
Study Selection
The PRISMA checklist is in Text S1. Studies were eligible for
inclusion if they reported the incidence of LTBI and TB disease in
prisons or if they reported the number of incident LTBI and TB
cases identified in the study along with the overall number of
inmates or prison personnel investigated or the person-years of
follow-up. LTBI incidence has been defined as tuberculin
conversion, that is newly positive tuberculin skin test (TST) after
a documented negative-baseline TST as reported in the original
study [6]. For TB disease incident cases we included both
definitive (microbiologically confirmed) and presumptive (based on
clinical, imaging, or pathology criteria) diagnoses. In order to
include studies of comparable quality, we considered only data
published in peer-reviewed journals. Thus data from unpublished
literature, such as Ministry of Health or Justice reports, were not
included.
We excluded studies with the following characteristics: (1)
reporting only case series; (2) reporting only outbreak investiga-
tions; (3) reporting only prevalence of LTBI and TB in prisons; (4)
reporting investigations targeted only to multi-drug resistant TB,
(5) case-control studies, (6) those starting before 1980. All duplicate
citations were eliminated from the initial database. Three
reviewers screened these citations by reviewing titles and abstracts
to identify potentially relevant studies. Disagreements between the
reviewers were resolved by consensus. The database was then
screened again to include only primary research articles, and the
full text of each citation was obtained and reviewed.
Data Extraction
A data extraction form was designed by three reviewers, then all
the papers were independently reviewed and data extraction was
cross-checked. Disagreements between the reviewers were resolved
by consensus.
The following datasets were collected from each study: country
where the study was performed, study period, incidence of LTBI/
TB and corresponding confidence intervals and/or the number of
incident LTBI and TB cases identified, and the overall number of
inmates or prison personnel investigated or the person-years of
follow-up, and if reported the incidence of LTBI and/or TB in a
comparison group, such as the local general population or prison
administrative workers not exposed to TB in the setting under
investigation.
To estimate TB incidence among the general populations in the
host countries, we used estimates provided by the WHO for the
corresponding study period (WHO Global Health Atlas [7]). To
estimate LTBI incidence among the general populations in the
host countries, we used estimates provided in the original papers
or, alternatively, as reported in the literature.
Data Analysis
For each study the incidence rate ratio (IRR) for LTBI and TB
in prison compared to the incidence in the general population was
calculated. The presence of heterogeneity across studies was
assessed by the conventional chi-squared test for heterogeneity (we
regarded a p-level below 0.05 as indicating significant heteroge-
neity in the data), and by calculating the I
2 statistic, which
accounts for the number of studies included in the meta-analysis
and provides a direct measure of the variability not explained by
the information included in the analysis [8]. We used STATA
version 9.2 (StataCorp, College Station, TX, USA) software for
statistical analysis.
In order to assess the fraction of LTBI or TB in the population
attributable to the exposure to prison settings, we calculated the
population attributable fraction percent (PAF%) using Levin’s
formula [9] PAF%~
Pe: IRR{1 ðÞ
1zPe: IRR{1 ðÞ
:100, where IRR is the
LTBI or TB IRR measured from each study and Pe is the
proportion of the population in prisons as given in the Human
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information provide slightly different figures, for example those
reported by the ‘‘International Centre for Prison Studies’’ of the
King’s College in London [11] are usually slightly higher than
those reported by the United Nations [10]; however, the data from
the two sources are consistent.
To investigate possible sources of heterogeneity, we stratified the
analysis according to income of the population in which the study
was conducted. In particular, we defined two strata, high- and
middle/low-income countries as classified by the World Bank [12].
Furthermore, to investigate potential sources of heterogeneity, we
tested, by means of univariate meta-regression analyses, the
possible effect of between-study variance of overcrowding,
presence/absence of ventilation systems, strategies of isolation of
suspected TB cases, and TST testing at entry as reported in each
study. We also tested the effect of study quality, which was assessed
using the Newcastle-Ottawa scoring scale for cohort studies [13].
In brief, the quality of the studies was assessed considering the
definition and representativeness of the cohort of inmates or prison
personnel, the diagnostic criteria for cases of active TB, and the
comparability of the cohorts on the basis of the study design or
analysis.
Results
The study selection process is shown in Figure 1. We identified
582 potentially relevant unique citations from all literature searches.
From 256 original primary studies, 23 studies [14–36] were
included, accounting overall for 670 cases of LTBI with 31,404
person-years of follow-up and for 1,710 cases of TB with 512,780
person-years of follow-up. Steenland et al. reported LTBI cases
among prison personnel separately, according to their ‘‘high’’ or
‘‘low’’ risk of being exposed to inmate cases of TB cases [30];
Russkikh et al. reported TB incidence among prison personnel in
Udmurt Republic (Russian Federation) during and following the
socioeconomic crisis that occurred in Russia in the late 1990s [35];
whereas Klopf et al. reported TB incidence rates before and after
the implementation of a TB control program in New York State
DepartmentofCorrectionalServices,separately[21].Wekeptthese
distinctions in our analyses. None of the selected studies reported
data from short-term correctional facilities.
The median number of cases per study of LTBI in prisons was
86 (interquartile range [IQR]: 49–169) and 68 for TB (IQR: 23–
214), while the median number of person-years of follow-up in
each study was 8,027 (IQR: 1,027–9,746) for LTBI and 13,869
(IQR: 3,927–81,759) for TB.
Figure 1. Flow diagram for study selection.
doi:10.1371/journal.pmed.1000381.g001
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studies were from the US (high-income country) and one study was
from Brazil (middle-income country). For studies reporting TB
data collected since 1981, 13 studies were from high-income
countries, six studies were from countries with an estimated
middle/low-income [16,22,29]. The geographic distribution of
studies reporting TB incidence was more heterogeneous.
Tables 1 and 2 summarize the findings of the six and 19 studies
that reported LTBI and TB incident cases in prisons, respectively.
In particular, for each study included in the review, we have
reported the period under investigation, the number of LTBI or TB
cases and the person-years at risk, the LTBI or TB incidence for the
comparison group representing the local general population, the
estimatedratedifference,the estimated IRRwiththe corresponding
95% confidence intervals (95%CIs), the incarcerated population
(per 1,000 inhabitants), and the estimated PAF%.
The median estimated annual incidence of LTBI in prisons was
2.6% (IQR: 1.3%–8.4%) overall and 2.1% (IQR: 1.3%–5.9%) for
studies from the US. The IRR for LTBI was 26.4 (IQR: 13.0–61.8)
overall and 21.6 (IQR: 13.0–59.1) for studies from the US. Figure 2
shows the distribution of the IRR for LTBI by income area.
The median estimated annual incidence of TB in prisons was
237.6 per 100,000 persons (IQR: 156–639) for studies from high-
income countries and 1,942.8 per 100,000 persons (IQR: 1,045.3–
2,777.8)forstudiesfrommiddle/low-incomecountries.Themedian
estimated IRR for TB were 17.9 (IQR: 8.6–61) and 32.8 (IQR:
15.4–36.1), respectively. The median difference between annual
incidence of LTBI measured in prisons as compared with that
measured in the general population was 2.5% (IQR: 1.2%–8.3%).
Since all the studies reporting data about LTBI incidence in
prisonsfrom high-income countries were from the US, we restricted
the analysis of TB incidence to studies from the US, in order to
compare incidence ratio ratios for LTBI and TB. The calculated
median estimate for TB was 48 (IQR: 24–114.5), which was higher
than the IRR of 32 (IQR: 19.6–44.3) found for LTBI, though the
distribution of these estimates largely overlapped (see above).
Figure 3 shows the distribution of the IRR for TB by income area.
Finally, using the estimated annual incidence of LTBI and
annual TB IRR and the reported population proportion of
inmates for each country of interest we estimated the PAF%. The
median population in prison (per 1,000 inhabitants) was 4.7 (IQR:
1.4–7.4) for high-income countries and 6.1 (IQR: 1.9–6.1) for
middle/low-income countries.
The median estimated PAF% for LTBI was 13.1% (IQR:
8.1%–30.0%) for studies from high-income countries (US) and
10.4% for the only study from a middle-income country. The
median estimated PAF% for TB was 8.5% (IQR: 1.9%–17.9%)
for studies from high-income countries and 6.3% (IQR: 2.7%–
17.2%) for studies from middle-low–income countries.
Figure 4 shows the PAF% (on a log scale) for TB as a function of
both the proportion of population in prison and the IRR between
prisoners and general population. As an example, Jones [20] and
Koffi [22] reported similar IRRs—34 and 33 respectively—but
due to the different proportions of the population that are in prison
the estimated PAF% diverge widely (19.7% versus 1.5%). On the
other hand, Fernandez de la Hoz and Wong [32] reported from
countries with similar proportions of incarcerated population, 1.4
and 1.7 per 1000 population respectively, but the large difference
in IRR produces a substantial shift in the estimated PAF% (4%
versus 0.4%).
The between-study heterogeneity was considerable. In partic-
ular, the overall I
2 statistic was 98% (95%CIs: 98%–99%); it was
98% (95%CIs: 97%–98%) for data from high-income countries
and 94% (95%CIs: 87%–97%) for data from middle/low-income
countries. The heterogeneity did not decrease significantly after
stratification by income of the countries. Similarly, accounting in
univariate metaregression analyses for overcrowding of the prison
setting, presence/absence of ventilation systems, strategies of
isolation of suspected TB cases, and TST or TB testing at entry
into prison did not show any significant effect on decreasing the
between-study variance. However, the IRR estimated from Wong
et al. [32], the study with the highest quality scoring, differed
significantly from the IRR estimated from studies with the lowest
quality scoring. However, no other significant difference was
attributable to studies’ quality scoring.
Discussion
In this study we attempt to summarize the published evidence of
incidence of both LTBI and TB in prisons. The present systematic
Table 1. Studies reporting LTBI incidence in prisons.
Author, Year
(Country) Period
Cases, n
(At Risk)
Incidence
in Prisons,
%
Incidence
in General
Population,
%
a
Incidence
Rate
Difference
IRR
(95%CI)
Incarcerated
Population,
61,000
Inhabitants
b PAF%
Ferreira et al., 1996 (Brazil) 1992–1993 21 (68) 30.9 0.5 30.4 61.76 (40.27–94.73) 1.91 10.4
Hung et al., 2003 (USA) 2000–2001 49 (9,746) 0.53 0.1 0.43 5.03 (3.8–6.65) 7.38 2.9
Koo et al., 1997 (USA) 1989–1991 130 (2,201) 5.91 0.1 5.81 59.06 (49.74–70.14) 7.38 30.0
MacIntyre et al., 1997 (USA) 1993–1994 86 (1,027) 8.37 0.1 8.27 83.74 (67.79–103.45) 7.38 37.9
Mitchell et al., 2005 (USA) 1999–2000 3 (231) 1.30 0.1 1.20 12.99 (4.19–40.27) 7.38 8.1
Steenland et al., 1997 (USA)
(high)
1991–1992 169 (10,104) 1.67 0.1 1.57 16.73 (14.39–19.45) 7.38 10.4
Steenland et al., 1997 (USA)
(low)
1991–1992 212 (8,027) 2.64 0.1 2.54 26.41 (23.08–30.22) 7.38 15.8
Characteristics of the study, estimated annual incidence of LTBI in prisons, estimated annual incidence of LTBI in the general population, estimated annual incidence of
LTBI difference, estimated annual incidence of LTBI ratio, fraction of the population in prison, fraction of LTBI in the population attributable to the exposure in prisons.
aAs reported in Menzies et al., 2007 [49]; Steenland et al. reported LTBI cases among prisons personnel separately according to their ‘‘high’’ or ‘‘low’’ risk of being
exposed to inmate cases of tuberculosis cases [30].
bAs reported in the the Human Development Report (year 2007/08) [47].
doi:10.1371/journal.pmed.1000381.t001
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middle/low-income countries, that the risk for TB is at least one
order of magnitude greater in prisons than in the general
population, as reported by Aerts et al. [37] in a questionnaire-
based survey from the WHO European Region. Analogous results
have been reported by Zarate et al. [38] in a review summarizing
Table 2. Studies reporting TB incidence in prisons, by income area according to the World Bank classification.
Income
Category
Author,
Year
(Country) Period
Cases, n
(At Risk)
Incidence
in Prisons,
6100,000
Incidence
in General
Population,
6100,000
Incidence
Rate
Difference
IRR
(95%CI)
Incarcerated
Population,
61,000
Inhabitants
{ PAF%
High-income
countries
Martin et al., 2001
(Spain)
1991–1999 NR 639
{ 45 594 14.2
(9.2–21.8)
1.45 1.88
Mor et al., 2008
(Israel)
1998–2004 23
(91,000)
25.3 10 15.3 2.5
(1.7–3.8)
2.09 0.32
Wong et al., 2008
(Hong Kong)
1999–2005 214
(82,406)
259.7 76 183.7 3.4
(3.0–3.9)
1.68 0.40
Ijaz et al., 2004
(USA)
1992–2000 58
(81,759)
70.9 10 60.9 7.1
(5.48–9.18)
7.38 4.30
Hanau-Bercot
et al., 2000
(France)
1991–1995 68
(31,546)
215.5 25 190.6 8.6
(6.8–10.9)
0.85 0.64
Valway et al., 1994
(USA)
1990–1992 171
(109,475)
156.2 9 147.2 17.3
(14.9–20.2)
7.38 10.77
Koo et al., 1997
(USA)
1991–1991 10
(5,421)
184.5 17.4 167.1 18.4
(9.9–34.3)
7.38 11.41
Klopf et al., 1998
(USA)
1991–1997* NR 225 9 216.0 25.0
(NA)
7.38 62.3
Klopf et al., 1998
(USA)
1991–1997** NR 61 9 52.0 6.8
(NA)
7.38 30.7
Fernandez de la
Hoz et al., 2001
(Spain)
1997–1997 97
(7,524)
1,289.2 40 1,249.2 32.2
(26.4–39.3)
1.45 4.33
Jones et al., 1999
(USA)
1995–1997 38
(13,869)
274.0 8 266.0 34.2
(24.9–47.1)
7.38 19.70
March et al., 2000
(Spain)
1994–1996 267
(3,927)
6,799.1 45 6,754.1 151.1
(134.0–170.3)
1.45 17.87
Chaves et al., 1997
(Spain)
1993–1994 216
(9,461)
2,283.1 30.4 2,252.7 75.1
(48.8–115.4)
1.45 9.70
Braun, 1989 (USA) 1984–1986 39
(36,967)
105.5 9 96.5 11.7
(8.6–16.0)
7.38 7.33
Middle/low
income
countries
Ferreira et al.,
1996 (Brazil)
#
1992–1993 20
(720)
2,777. 8 77 2,700.8 36.1
(23.3–55.9)
1.91 6.28
de Oliveira et al.,
2004 (Brazil)
1993–2000 359
(34,344)
1,045.3 67.75 977.5 15.4
(13.9–17.1)
1.91 2.68
Russkikh et al.,
2007 (Russia)
1996–2000
{ NR 2,035.3 58.0 1,977.3 35.1
(NA)
6.11 17.2
Russkikh et al.,
2007 (Russia)
2001–2005
{ NR 1,649.9 71.6 1,578.3 23.0
(NA)
6.11 11.9
Pavlov et al., 2003
(Russia)
1998–2000 NR 1,942.8 49.6 1,893.2 39.1
(NA)
6.11 18.9
Slavuckij et al,
2002 (Russia)
1998–1998 22
(2,500)
880 100 780 8.8
(5.8–13.4)
6.11 4.55
Koffi et al., 1997
(Ivory Coast)
1990–1992 108
(1,861)
5,803.3 177 5,626.3 32.8
(27.1–39.6)
0.49 1.53
Source: [12]. Characteristics of the study, estimated annual tuberculosis (TB) incidence in prisons, estimated annual TB incidence in the general population, estimated annual
TB incidence difference, estimated annual TB incidence ratio, fraction of the population in prison, fraction of TB in the population attributable to the exposure in prisons.
{As reported in the Human Development Report (year 2007/08) [47].
{As reported in Martin et al., 2001 [26].
#Female inmates only.
Klopf et al. reported TB incidence *before and **after the implementation of a TB control program in New York State Department of Correctional Services and prisons
personnel separately [21].
Russkikh et al. reported TB incidence among prison personnel
{during and
{following the socioeconomic crisis occurred in Russia in the late 1990s [35].
NA, not applicable; NR, not reported.
doi:10.1371/journal.pmed.1000381.t002
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Committee of the Red Cross and the WHO.
The magnitudes of IRR for LTBI and TB estimated in the
present systematic review are consistent with each other. Further-
more the finding that the median IRR for LTBI (26.4; IQR: 13.0–
61.8) is comparable to that for TB (23.0; IQR: 11.7–36.1) is in line
with findings from previous reports and suggests that incident TB
cases have a greater impact on subsequent transmission than does
importation of LTBI [39]. However, in settings where screening is
performed at entry in prison, incident TB cases may represent some
LTBI importation. Direct evidence, based on molecular genotyping
and drug susceptibility testing, of TB transmission in prisons was
recently provided by Matthys et al. [40].
Although in some countries the number of TB cases in prisons
represents a relevant proportion of the overall burden of the
disease, data on TB in prisons are not always reported to ministries
of health [41]. Thus, the TB incidence statistics used for
international reporting may be flawed. This underreporting may
help to limit a potential bias in our estimates for the IRR (and
therefore PAF%), with prisoners being compared to a truly
unexposed population; by contrast, if in some countries data from
prisons were merged with that of the general population, IRR
could have been underestimated. However, those who enter and
exit prisons are more likely to belong to population subgroups at a
higher risk for LTBI and TB disease than the general population,
such as illegal immigrants, hard-to-reach people (such as the
homeless), and underserved ethnic-social minorities. A higher risk
of transmission outside of the prisons with respect to the general
population may lead to an overestimation of IRRs, since a fraction
of the transmission occurring within the community would be
attributed to the prison setting.
The PAF% values given here should be considered estimates of
the real impact of transmission of TB within prisons, depicting the
two main forces acting on such an impact: the proportion of the
population in prison and the role of measures to control
transmission. The method adopted to estimate the PAF% was
developed to measure the impact on a population of risk factors for
noncommunicable diseases [9] and does not account for the
transmission dynamics of infectious diseases. In particular, it does
not capture the indirect effects of preventive strategies devised to
interrupt the chain of disease transmission. Thus, our estimates
cannot capture the consequences of introducing TB control
measures on transmission dynamics within a prison or between a
prison and the local community [1]. Incarcerated people and prison
staff can move to different institutions within the judiciary system
and to health centers. Plus, prisoners and prison staff have contact
with visitors, and prisoners can be freed without a diagnosis or
beforehaving completed therapy [3,41]. As a consequence,not only
have prison outbreaks of TB been linked to an increased incidence
of TB in local communities, butmass incarcerationin CentralAsian
and Eastern European countries has been associated with the
increase of TB rates in the general population [4].
Education on early identification of TB and early case manage-
ment, screening of inmates at arrival, isolation of cases with positive
sputum smears—within the framework of community health services
when necessary [5,42]—all represent potentially effective measures.
Their implementation is, however often hampered by resource
constraints specific to the prison setting. Nevertheless, emphasis
should always be placed on control of TB transmission, especially in
periods of growth of prison populations [4].
In high- and middle/low-income countries, the maximum
possible reduction of the median TB annual incidence in prisons
was estimated to be 187 and 1,893 per 100,000 population,
respectively. Although assessing the cost-effectiveness of the
introduction of TB transmission control measures is beyond the
scope of this paper, such a potential reduction of TB incidence in
prisonswould make attractive a range of infection control strategies.
The PAF% for TB and LTBI in high- and medium/low-income
countries ranges from 4.5% to 10.4%; however, figures for high-
income countries are driven by data from the US, the country with
the largest prison population. Nonetheless, data from the US could
provide useful insights into the epidemiology of TB in prisons: The
Figure 2. Forest plot showing the study-specific estimates of the IRRs for LTBI in prisons as compared to corresponding general
populations, by income area according to the World Bank classification. Source: [12].
doi:10.1371/journal.pmed.1000381.g002
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by Klopf et al. [21] showed that a reduction of IRR from 25 to 6.8
may have halved the PAF% from 62.3% to 30.7%.
Unfortunately, there is a lack of data from Africa and Central
Asia, so it is unclear to what extent these findings can be generalized
to other countries, with factors such as inadequate nutrition and
HIV prevalence [43] possiblyplaying substantial roles.Limited data
from the Russian Federation seem to support our findings. A
limitation of the present study is that few reviewed papers stratified
the prison population for relevant risk factors such as HIV status.
The present findings should be interpreted in the light of some
study limitations. The high heterogeneity between studies did not
allow a pooled analysis of the data; similar levels of heterogeneity
have been observed in other systematic reviews focusing on control
of TB transmission and those analyzing observational studies
[44,45]. Such heterogeneity can be due to differences in methodo-
logical quality, study design, sampling variability, and study
populations across studies. Unfortunately, the meta-regression
analyses testing for the potential effect on the between-study
heterogeneity of prison overcrowding, implementation of TB
infection control interventions, strategies of isolation of suspected
TB cases, TST or TB testing upon entry into prison, and study
quality scoring did not show any significant role for these factors.
In particular, we were unable to account for the duration of time
that inmates spend in prisons. Furthermore, we could not account
for specific patterns of incarceration, since the classification and
organization of detention centers differ between countries.
It has been shown that the direct comparison of the TB rates
estimated in prisons from the same area but with different
characteristics may differ significantly [46]. Furthermore, the best
available estimates of LTBI incidence in general population should
be regarded cautiously, since they are not drawn from random
samples of the population. Meanwhile, information on factors
potentially affecting the TST result interpretation such as BCG
(bacille Calmette-Gue ´rin) status and nontuberculous mycobacteria
distribution in the local population are not available.
The PAF% estimates given here rely on a few key assumptions
that cannot be assessed directly. The first assumption is that the
proportion of the population in prisons as reported by the Human
Development Report [47] is reliable and applicable to the specific
prison setting investigated in the reviewed studies. The second is
that the IRR for TB remains relatively constant over time; in fact,
fluctuations of the IRR may occur within a decade or more [48].
In conclusion, these findings provide a detailed summary of the
evidence on LTBI and TB risk and incidence in prisons
attributable to within-prison spread of TB and make it possible to
estimate the impact at a population level. These data may prove
useful to inform the development of rational policies to control TB
Figure 3. Forest plot showing the study-specific estimates of the IRR for tuberculosis in prisons as compared to the corresponding
general populations, by income area according to the World Bank classification. Source: [12]. NA, not applicable.
doi:10.1371/journal.pmed.1000381.g003
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population attributable risk of prison-to-community spread and
describe the conditions in the prison that influence TB transmission.
Reporting on the factors potentially affecting the rates of transmission
within the different prisons should reduce the heterogeneity of the
reported findings and may help us understand the main reasons for
the differences in transmission in different settings.
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Background. Every year, nearly 10 million people develop
tuberculosis (TB)—a contagious bacterial infection usually of
the lungs—and nearly two million people die from the
disease. TB is caused by Mycobacterium tuberculosis, which
spreads in airborne droplets when people with the disease
cough or sneeze. Most people infected with M. tuberculosis
never become ill—their immune system contains the
infection. However, the bacteria remain dormant (latent)
within the body, and a latent TB infection (LTBI) can cause
active disease many years after the initial infection if host
immunity declines. The symptoms of TB include a persistent
cough, weight loss, and night sweats. Infection with M.
tuberculosis can be diagnosed using the tuberculin skin test;
tests for TB itself include chest X-rays and sputum cultures (in
which bacteriologists try to grow M. tuberculosis from
sputum samples, mucus brought up from the lungs by
coughing). TB can usually be cured by taking several
powerful antibiotics daily for several months.
Why Was This Study Done? Last century, global control
efforts began to reduce the incidence (number of new cases
in a population in a given time) and prevalence (the number
of affected people in a population) of LTBI and TB in many
countries. Now, the emergence of antibiotic-resistant
bacterial strains is thwarting these efforts. Consequently, it
is important to identify settings where TB transmission is
particularly high. One such setting is thought to be prisons.
In these facilities, overcrowding, late case detection,
inadequate treatment, and poor implementation of
infection control measures (including incomplete
segregation of people with active TB) might increase the
TB transmission rate. However, it is not known how many
people in prison become infected with M. tuberculosis or
develop TB each year compared to the general population
nor what percentage of LTBI and TB in the general
population is attributable to exposure to M. tuberculosis in
prison (the population attributable fraction or PAF%). Here,
the researchers undertake a systematic review (a study that
uses predefined criteria to identify all the research on a given
topic) to investigate the incidence of TB in prisons.
What Did the Researchers Do and Find? Theresearchers
identified 23 studies that reported the incidence of LTBI and/
or TB in prisons among both staff and prisoners. They
estimated the incidence of TB in relevant general populations
using World Health Organization data; estimates of the
incidence of LTBI in the general population came from the
studies themselves. The researchers then calculated the ratio
between the incidence rates for LTBI and TB in prison and in
the general population (incidence rate ratios or IRRs) for each
study. For both LTBI and TB, the IRR varied widely between
studies. The average IRR for LTBI was 26.4. That is, the average
incidence of LTBI in prisons was 26.4 times higher than in the
general population; the average IRR for TB was 23.0. The
researchers also estimated the fraction of TB in the general
population attributable to within-prison exposure to M.
tuberculosis for each study. Again, there was considerable
heterogeneity between the studies but, on average, the PAF%
for TB in high-income countries was 8.5% (that is, one in 11
cases of TB in the general population was attributable to
within-prison spread of TB); in middle-to-low–income
countries, the average PAF% was 6.3%.
What Do These Findings Mean? These findings suggest
that the risk of LTBI and TB is at least an order of magnitude
higher in prisons than in the general population and that the
within-prison spread of LTBI and TB is likely to substantially
affect the incidence of LTBI and TB in the general population.
The accuracy and generalizability of these findings are
limited by the small number of studies identified, by the
relative paucity of studies from countries other than the USA,
by study heterogeneity, and by assumptions made in the
calculation of PAF%. Even so, these findings suggest that
improvements in TB control in prisons would not only help
to protect prisoners and staff from within-prison spread of TB
but would also reduce national TB burdens. Further studies
are now needed to identify the specific conditions in prisons
that influence TB transmission so that rational policies can be
developed to improve TB control in correctional facilities.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1000381.
N This study is discussed in the December 2010 PLoS
Medicine Editorial
N The World Health Organization provides information on all
aspects of TB, including information on TB in prisons and
on the Stop TB Partnership (some information is in several
languages)
N The US Centers for Disease Control and Prevention has
information about TB and on TB in prisons
N The US National Institute of Allergy and Infectious Diseases
also has detailed information on all aspects of TB
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